Shree Ganesh Remedies Limited (BOM:540737)

Market Cap	6.81B -27.0%
Revenue (ttm)	1.01B -17.6%
Net Income	180.82M -36.5%
EPS	14.08 -36.5%
Shares Out	12.84M
PE Ratio	37.68
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,396
Average Volume	3,713
Open	548.40
Previous Close	488.35
Day's Range	512.00 - 548.40
52-Week Range	381.10 - 794.00
Beta	0.36
RSI	59.74
Earnings Date	May 21, 2026

About Shree Ganesh Remedies

Shree Ganesh Remedies Limited engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India and internationally. The company offers anti-arrhythmic, anti-cancer, anti-depressant, anti-diabetic, anti-diarrheal, antifungal, antihistamine, anti-inflammatory, anti-parasitic, anti-psychotic, anticholinergic, birth-control, cardiovascular, gastrointestinal, neurological disorder, ophthalmic, opioid, and veterinary API intermediates. It also provides fine and specialty c...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1995
• Employees: 149
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540737

Financial Performance

In fiscal year 2025, Shree Ganesh Remedies's revenue was 1.09 billion, a decrease of -13.74% compared to the previous year's 1.26 billion. Earnings were 230.68 million, a decrease of -17.93%.